EASTLAND JULIA MARIE

CIK 00015001896 companiesBEDFORD, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001500189

Recent Transactions

50 trades

Award
Lantheus Holdings, Inc.$LNTH
Common Stock
2026-05-14+4,137→ 8,019 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2026-02-09$2.39/sh−889→ 79,133 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2026-02-06$2.43/sh−7,866→ 80,022 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2026-01-08+775,000→ 775,000 total
Award
Lantheus Holdings, Inc.$LNTH
Common Stock
2025-05-14+2,537→ 3,882 total
Award
Lantheus Holdings, Inc.$LNTH
Stock Option (right to buy)
2025-05-14+4,543→ 4,543 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2025-02-03+59,388→ 87,888 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2025-02-03+59,388→ 59,388 total
Purchase
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2025-01-31$1.73/sh+28,500→ 28,500 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2024-12-02+3,028,800→ 3,028,800 total
Award
Lantheus Holdings, Inc.$LNTH
Common Stock
2024-09-10+1,345→ 1,345 total
Award
Lantheus Holdings, Inc.$LNTH
Stock Option (right to buy)
2024-09-10+2,506→ 2,506 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2024-05-23+22,500→ 22,500 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-05-23+5,357→ 16,071 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2024-03-11−40,759→ 0 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2024-03-11+31,250→ 269,381 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2024-03-11−2,765→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock
2024-03-11−269,381→ 0 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2024-01-07+178,500→ 232,003 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-11-26+50,000→ 53,503 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2023-05-26+22,500→ 22,500 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-05-26+5,357→ 10,714 total
Disposition to Issuer
CalciMedica, Inc.$CALC
Common Stock
2023-03-23+1,429→ 1,429 total
Disposition to Issuer
CalciMedica, Inc.$CALC
Restricted Stock Unit
2023-03-23−1,429→ 0 total
Award
Harpoon Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-24+407,600→ 407,600 total
Award
CalciMedica, Inc.$CALC
Restricted Stock Units
2022-06-02+20,000→ 20,000 total
Award
CalciMedica, Inc.$CALC
Stock Option (Right to Buy)
2022-06-02+20,000→ 20,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2022-05-26+5,357→ 5,357 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2022-05-26+22,500→ 22,500 total
Award
Harpoon Therapeutics, Inc.
Stock Option (Right to Buy)
2021-11-08+350,000→ 350,000 total
Award
CalciMedica, Inc.$CALC
Employee Stock Option (Right to Buy)
2021-06-02+12,500→ 12,500 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2021-05-28+25,000→ 25,000 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 total
Award
CalciMedica, Inc.$CALC
Director Stock Option (Right to Buy)
2020-09-24+25,000→ 25,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2020-07-17+50,000→ 50,000 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2020-05-28+10,167→ 10,167 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2019-06-03+10,167→ 10,167 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2019-02-07+5,907→ 5,907 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−41,667→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−50,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−16,500→ 0 total
Disposition from Tender
Cascadian Therapeutics, Inc.
Common Stock
2018-03-09−5,237→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−6,667→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−8,334→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−8,334→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−25,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−16,667→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−75,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−199,000→ 0 total

Companies

Recent Filings

Address

C/O LANTHEUS HOLDINGS, INC. 201 BURLINGTON ROAD, SOUTH BUILDING

BEDFORD, MA, 01730

View on SEC.gov